27618734|t|Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas
27618734|a|Conflicting data exist regarding the contribution of human papillomavirus (HPV) to the development of head and neck squamous cell papillomas. Formalin-fixed paraffin-embedded papillomas were tested for 28 mucosal and 79 cutaneous HPVs using polymerase chain reaction (PCR)-based methods. Eighty-three papillomas (43 oropharyngeal, 31 oral, 6 laryngeal, and 3 nasopharyngeal) were analyzed. Twenty-four samples (28.9%) harbored mucosal HPVs: 3 oropharyngeal (6.9%), 15 oral (48.3%), 4 laryngeal (66.7%), and 2 nasopharyngeal papillomas (66.7%). Eighty-one cases were also tested for cutaneous HPVs, detected in 16 lesions (19.7%): 11 (13.5%) harbored only cutaneous types, and 5 (6.2%) were positive for both cutaneous and mucosal HPVs. Among these 81 cases, prevalence of mucosal and/or cutaneous HPV infection was 43.2%. HPV DNA detection in a fraction of head and neck papillomas supports the role of HPV in their development. However, other markers need to be considered to confirm the association of HPV infection with these lesions. Â© 2016 Wiley Periodicals, Inc. Head Neck 39: 254-259, 2017.
27618734	0	7	Mucosal	T017	UMLS:C0026724
27618734	12	21	cutaneous	T082	UMLS:C0221912
27618734	22	44	human papillomaviruses	T005	UMLS:C0021344
27618734	48	52	head	T082	UMLS:C0018670
27618734	57	61	neck	T082	UMLS:C0027530
27618734	62	86	squamous cell papillomas	T038	UMLS:C0205874
27618734	140	160	human papillomavirus	T005	UMLS:C0021344
27618734	162	165	HPV	T005	UMLS:C0021344
27618734	189	193	head	T082	UMLS:C0018670
27618734	198	202	neck	T082	UMLS:C0027530
27618734	203	227	squamous cell papillomas	T038	UMLS:C0205874
27618734	229	272	Formalin-fixed paraffin-embedded papillomas	T038	UMLS:C0030354
27618734	292	299	mucosal	T017	UMLS:C0026724
27618734	307	316	cutaneous	T082	UMLS:C0221912
27618734	317	321	HPVs	T005	UMLS:C0021344
27618734	328	373	polymerase chain reaction (PCR)-based methods	T062	UMLS:C0032520
27618734	388	398	papillomas	T038	UMLS:C0030354
27618734	403	416	oropharyngeal	T082	UMLS:C0521367
27618734	421	425	oral	T082	UMLS:C0226896
27618734	429	438	laryngeal	T017	UMLS:C0023078
27618734	446	460	nasopharyngeal	T017	UMLS:C0027442
27618734	467	475	analyzed	T062	UMLS:C0936012
27618734	514	521	mucosal	T017	UMLS:C0026724
27618734	522	526	HPVs	T005	UMLS:C0021344
27618734	530	543	oropharyngeal	T082	UMLS:C0521367
27618734	555	559	oral	T082	UMLS:C0226896
27618734	571	580	laryngeal	T017	UMLS:C0023078
27618734	596	610	nasopharyngeal	T017	UMLS:C0027442
27618734	611	621	papillomas	T038	UMLS:C0030354
27618734	669	678	cutaneous	T082	UMLS:C0221912
27618734	679	683	HPVs	T005	UMLS:C0021344
27618734	685	693	detected	T033	UMLS:C0442726
27618734	700	707	lesions	T033	UMLS:C0221198
27618734	742	751	cutaneous	T082	UMLS:C0221912
27618734	777	785	positive	T033	UMLS:C1446409
27618734	795	804	cutaneous	T082	UMLS:C0221912
27618734	809	816	mucosal	T017	UMLS:C0026724
27618734	817	821	HPVs	T005	UMLS:C0021344
27618734	859	866	mucosal	T017	UMLS:C0026724
27618734	874	883	cutaneous	T082	UMLS:C0221912
27618734	884	897	HPV infection	T038	UMLS:C0343641
27618734	909	926	HPV DNA detection	T058	UMLS:C0201678
27618734	944	948	head	T082	UMLS:C0018670
27618734	953	957	neck	T082	UMLS:C0027530
27618734	958	968	papillomas	T038	UMLS:C0030354
27618734	990	993	HPV	T005	UMLS:C0021344
27618734	1091	1104	HPV infection	T038	UMLS:C0343641
27618734	1116	1123	lesions	T033	UMLS:C0221198